27 studies found for:    " December 17, 2008":" January 16, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Conditions: Acquired Immune Deficiency Syndrome;   AIDS;   Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Other: Standard treatment regimen
2 Completed Safety of the HIV Vaccine 732461 in HIV Infected Subjects Aged 18 to 55 Years Old
Condition: HIV (Human Immunodeficiency Virus)-Infected Adults
Interventions: Biological: HIV Vaccine 732461;   Biological: Placebo vaccine
3 Unknown  Effective Aids Treatment and Support in the Free State (FEATS)
Conditions: HIV/AIDS;   Food Insecurity;   HIV Infections
Interventions: Behavioral: ARV peer adherence support (PAS);   Dietary Supplement: Nutritional support;   Drug: ARV treatment
4 Completed Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers
Condition: Human Immunodeficiency Virus (HIV) Infection
Intervention: Drug: maraviroc (Selzentry, Celsentri)
5 Unknown  Alveolar Macrophage Proteomics in HIV-associated Emphysema
Conditions: HIV;   Emphysema;   HIV Infections
Intervention:
6 Completed Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults
Condition: HIV Infections
Interventions: Biological: DNA Vaccine;   Biological: Placebo;   Biological: rMVA vaccine
7 Completed Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: efavirenz;   Drug: raltegravir
8 Completed Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy
Conditions: Pregnancy;   Malaria;   HIV Infections
Interventions: Drug: Sulphadoxine-pyrimethamine;   Drug: Mefloquine (full dose);   Drug: Mefloquine (split dose);   Drug: placebo;   Drug: mefloquine
9 Completed Renal Function Assessment in HIV Patient
Conditions: Chronic Kidney Disease;   HIV Infections
Intervention: Other: DEXA scan
10 Recruiting The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study
Conditions: Cancer;   HIV Infections
Intervention:
11 Terminated
Has Results
A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1
Condition: HIV-1
Intervention: Drug: No drug will be administered
12 Completed
Has Results
A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1
Condition: HIV-1
Interventions: Drug: UK-453, 061;   Drug: EFV +TVA
13 Completed Beta-2 Microglobulin and Serum Cytokines x HAART
Condition: HIV Patients
Intervention:
14 Completed Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs)
Conditions: HIV/AIDS;   HIV Infections
Intervention: Drug: ETHINYL ESTRADIOL AND LEVOGESTREL
15 Completed TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation
Conditions: Pharmacokinetics;   Bioavailability;   HIV-1
Intervention: Drug: TMC278
16 Terminated Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
Conditions: HIV Infections;   Helminthiasis
Intervention: Drug: Praziquantel, Ivermectin, Albendazole
17 Terminated
Has Results
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
Condition: HIV-1
Interventions: Drug: UK-453,061 Dose 1;   Drug: UK-453,061 Dose 2;   Drug: Etravirine
18 Completed Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
Conditions: HIV Infection;   Fungal Infection
Interventions: Drug: Posaconazole;   Drug: Fosamprenavir;   Drug: Ritonavir
19 Completed
Has Results
Comparative Study of Three NNRTI-Sparing HAART Regimens
Condition: HIV Infection
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Atazanavir
20 Completed
Has Results
Chloroquine for Reducing Immune Activation in HIV- Infected Individuals
Condition: HIV Infections
Interventions: Drug: Chloroquine;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years